Lurasidone hydrochloride

This classification denotes a serotonin antagonist and dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0P4I5851I. European Medicines Agency schedules Lurasidone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34204. Lurasidone hydrochloride generally arises in the molecular formula C28H36N4O2S.CLH. The term 'lurasidone hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule lurasidone hydrochloride under HS 29341000 and SITC 51579. As of Q4 2014, LURASIDONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lurasidone hydrochloride bears US NLM identifiers UMLS ID C2003425 and NCI Concept Code C77576. SMILES: C1CCC2C(C1)C(NS2)N3CCN(CC3)C[C@@H]4CCCC[C@H]4CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O.CL.